DiscoverThe Long Run with Luke TimmermanEp151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

Update: 2023-12-26
Share

Description

Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.
Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders

Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders

2025-02-1157:56

Ep172: Mostafa Ronaghi on Studying Live Cells at Scale

Ep172: Mostafa Ronaghi on Studying Live Cells at Scale

2025-01-2701:20:53

Ep171: Ram Aiyar on RNA Editing Medicines

Ep171: Ram Aiyar on RNA Editing Medicines

2025-01-1301:01:48

Ep170: David Schenkein on Investing in the Future of Biotech

Ep170: David Schenkein on Investing in the Future of Biotech

2025-01-0259:52

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

2024-12-1101:02:28

Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

2024-11-2501:00:23

Ep167: Leslie Williams on transfer RNA therapies

Ep167: Leslie Williams on transfer RNA therapies

2024-11-0601:11:28

Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity

Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity

2024-10-1501:03:35

Ep165: Zach Hornby on Tackling Cancer Drug Resistance

Ep165: Zach Hornby on Tackling Cancer Drug Resistance

2024-09-2601:02:45

Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

2024-09-0556:39

Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

2024-08-1401:08:16

Ep162: Sean McClain on AI for Biologic Drug Discovery

Ep162: Sean McClain on AI for Biologic Drug Discovery

2024-07-1601:05:59

Ep161: Jeff Stein on a Long-Lasting Flu Drug

Ep161: Jeff Stein on a Long-Lasting Flu Drug

2024-07-0101:08:51

Ep160: Abe Ceesay on Precision Neuroscience

Ep160: Abe Ceesay on Precision Neuroscience

2024-06-1701:08:48

Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

2024-06-0301:07:22

Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

2024-05-2001:00:44

Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

2024-05-0156:33

Ep156: David Liu on New Tools and Techniques for Biology

Ep156: David Liu on New Tools and Techniques for Biology

2024-04-1601:52:57

Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

2024-03-0601:02:37

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

2024-02-0901:03:14

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

Timmerman Report